Bone Biologics BBLGW
NASDAQ BBLGW
$8.24 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bone Biologics Corp (BBLGW) Payables (2013 - 2025)

Bone Biologics (BBLGW) posted quarterly Payables of $417884.0 for Q4 2025, up 12.02% year-over-year from $373042.0 in Q4 2024, and up 25.46% quarter-over-quarter from $333081.0 in Q3 2025.

Bone Biologics Corp (BBLGW) Payables (2013 - 2025) Analysis & Trends

Bone Biologics (BBLGW) has reported Payables for 13 consecutive years, with $417884.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Payables rose 12.02% year-over-year to $417884.0; the TTM figure through Dec 2025 stood at $417884.0 (up 12.02% YoY), while the FY2025 annual figure was $417884.0, up 12.02% from the prior year.
  • Payables rose to $417884.0 in Q4 2025 per BBLGW's latest filing, from $333081.0 in the prior quarter.
  • Across five years, Payables topped out at $12.8 million in Q3 2021 and bottomed at $54913.0 in Q1 2022.
  • Historically, Payables has averaged $2.3 million across 5 years, with a median of $366852.0 in 2023.
  • Annual changes were most pronounced in 2022 — Payables sank 99.56% — and 2023, when it jumped 4050.55%.
  • Bone Biologics' Payables stood at $99909.0 in 2021, then increased by 4.88% to $104786.0 in 2022, then soared by 244.19% to $360662.0 in 2023, then gained by 3.43% to $373042.0 in 2024, then climbed by 12.02% to $417884.0 in 2025.
  • Business Quant data shows BBLGW's Payables at $417884.0 in Q4 2025, $333081.0 in Q3 2025, and $403729.0 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 417,884.00
Sep 30, 2025 333,081.00
Jun 30, 2025 403,729.00
Mar 31, 2025 247,843.00
Dec 31, 2024 373,042.00
Sep 30, 2024 190,057.00
Jun 30, 2024 231,872.00
Mar 31, 2024 146,186.00
Dec 31, 2023 360,662.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.69 Mn
Mar 31, 2023 2.28 Mn
Dec 31, 2022 104,786.00
Sep 30, 2022 799,475.00
Jun 30, 2022 70,636.00
Mar 31, 2022 54,913.00
Dec 31, 2021 99,909.00
Sep 30, 2021 12.84 Mn
Jun 30, 2021 12.58 Mn
Mar 31, 2021 12.43 Mn